Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of a safety and efficacy analysis

被引：0
|
作者：
Arkenau, HT
Schmoll, H
Kubicka, S
Kretzschmar, A
Freier, W
Seufferlein, T
Graeven, U
Grothey, A
Hinke, A
Porschen, R
机构：
[1] Clin Bremen E, Clin Internal Med, Bremen, Germany
[2] Univ Halle Wittenberg, Halle Saale, Germany
[3] Hannover Med Sch, D-3000 Hannover, Germany
[4] Charite, Berlin, Germany
[5] Private Oncol Clin, Hildesheim, Germany
[6] Univ Ulm, Med Clin, Ulm, Germany
[7] Hosp Maria Hilf, Monchengladbach, Germany
[8] Mayo Clin, Rochester, MN USA
[9] Res Inst WISP Langenfeld, Res Inst WISP, Langenfeld, Germany
[10] Clin Bremen E 10, Bremen, Germany
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [41] CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA
    Taieb, Julien
    Maughan, Tim
    Bokemeyer, Carsten
    Van Cutsem, Eric
    Brodowicz, Thomas
    Folprecht, Gunnar
    Esser, Regina
    Schlichting, Michael
    Tabernero, Josep
    ANNALS OF ONCOLOGY, 2012, 23 : 11 - 11
  • [42] A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
    F De Vita
    M Orditura
    E Matano
    R Bianco
    C Carlomagno
    S Infusino
    V Damiano
    E Simeone
    M R Diadema
    E Lieto
    P Castellano
    S Pepe
    S De Placido
    G Galizia
    N Di Martino
    F Ciardiello
    G Catalano
    A R Bianco
    British Journal of Cancer, 2005, 92 : 1644 - 1649
  • [43] Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)
    Martoni, Andrea Angelo
    Pinto, Carmine
    Di Fabio, Francesca
    Lelli, Giorgio
    Rojas Llimpe, Fabiola Lorena
    Gentile, Anna Lisa
    Mutri, Vita
    Ballardini, PierLuigi
    Giaquinta, Stefania
    Piana, Edera
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (18) : 3161 - 3168
  • [44] A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
    De Vita, F
    Orditura, M
    Matano, E
    Bianco, R
    Carlomagno, C
    Infusino, S
    Damiano, V
    Simeone, E
    Diadema, MR
    Lieto, E
    Castellano, P
    Pepe, S
    De Placido, S
    Galizia, G
    Di Martino, N
    Ciardiello, F
    Catalano, G
    Bianco, AR
    BRITISH JOURNAL OF CANCER, 2005, 92 (09) : 1644 - 1649
  • [45] A PHASE II STUDY OF BIWEEKLY OXALIPLATIN PLUS INFUSIONAL 5-FLUOROURACIL AND FOLINIC ACID (FOLFOX4) AS FIRST-LINE TREATMENT OF ADVANCED GASTRIC CANCER PATIENTS
    De Vita, Ferdinando
    Orditura, Michele
    Matano, Elide
    Bianco, Roberto
    Carlomagno, Chiara
    Infusino, Stefania
    Damiano, Vincenzo
    Simeone, Ester
    Diadema, Maria Rosaria
    Lieto, Eva
    Castellano, Paolo
    Pepe, Stefano
    De Placido, Sabino
    Galizia, Gennaro
    Ciardiello, Fortunato
    Catalano, Giuseppe
    Bianco, Angelo Raffaele
    ANNALS OF ONCOLOGY, 2004, 15 : 76 - 76
  • [46] Safety and efficacy of outpatient treatment with CPT-11 plus bolus folinic acid/5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer
    Moehler, M
    Hoffmann, T
    Zanke, C
    Hohl, H
    Burg, H
    Ehscheid, P
    Schwindt, P
    Adami, B
    Schroeder, M
    Klein, O
    Baldus, M
    Galle, PR
    Heike, M
    ANTI-CANCER DRUGS, 2003, 14 (01) : 79 - 85
  • [47] Cost-minimization analysis of capecitabine plus oxaliplatin (XELOX) vs. infusional 5-FU/LV + oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer (MCRC) in the French setting
    Perrocheau, G.
    Ducreux, M.
    Hebbar, M.
    Ychou, M.
    Lledo, G.
    Conroy, T.
    Faroux, R.
    Douillard, J. Y.
    Pacull, A.
    VALUE IN HEALTH, 2007, 10 (06) : A233 - A233
  • [48] S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: Updated results from a phase 3 trial.
    Park, Young Suk
    Kim, Seung
    Hong, Yong Sang
    Lim, Ho Yeong
    Lee, Jeeyun
    Kim, Tae Won
    Kim, Kyu-Pyo
    Kim, Sun Young
    Baek, Ji Yeon
    Kim, Jee Hyun
    Lee, Keun-Wook
    Chung, Ik-Joo
    Cho, Sang-Hee
    Lee, Kyung Hee
    Shin, Sang Joon
    Kang, Hye Jin
    Shin, Dong Bok
    Jo, Sook Jung
    Lee, Jae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Efficacy and Safety of Docetaxel Plus Oxaliplatin and Capecitabine in the First Line Treatment of Advanced Gastric Adenocarcinoma
    Liu, Ying
    Ye, Zhengbao
    Xi, Wenqi
    Ma, Tao
    Shi, Min
    Yang, Liu
    Zhu, Zhenggang
    Zhang, Jun
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [50] Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA study.
    Martoni, A
    Pinto, C
    Di Fabio, F
    Lelli, G
    Gentile, AL
    Llimpe, FLR
    Mutri, V
    Ballardini, PL
    Giaquinta, S
    Piana, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 275S - 275S
12345